Updates

News & Milestones

Building the scientific and clinical foundation for resistance forecasting and predictive infection intelligence

FEATURED
Leadership Recognition

CEO Kalen Hall named Executive of the Year by Biz New Orleans

Biz New Orleans profiled Informuta Cofounder and CEO Kalen Hall for her work building a new approach to antimicrobial resistance and the team's vision for predictive infection intelligence.

FEATURED
Informuta team at ribbon cutting ceremony for new clinical lab at NOBIC
Partnership & Expansion

Informuta opens clinical lab headquarters and expands partnership with Ochsner Health

Informuta has opened a new clinical lab at the New Orleans BioInnovation Center, bringing its clinical research operations to New Orleans and expanding its strategic partnership with Ochsner Health.

The new facility supports pilots and clinical validation studies—including at Ochsner—accelerating translation of Informuta's sequencing- and AI-enabled infectious disease intelligence platform into real clinical settings.

FEATURED
Nature Communications
Scientific Publication

Published in Nature Communications

Our peer-reviewed research validates the ability to forecast treatment-emergent resistance through bacterial mutational signatures in Pseudomonas aeruginosa, one of the most difficult-to-treat healthcare-associated pathogens. This publication establishes the scientific foundation for our platform and demonstrated 92-100% accuracy across two independent cohorts.

Progress

Additional Milestones

Funding Major Milestone

NSF Phase I STTR Grant

Received $275,000 in funding from the National Science Foundation to advance antimicrobial resistance research and development.

Partnership Strategic Location

JLABS Residency

Established presence at Johnson & Johnson Innovation Labs in San Diego, California, gaining access to world-class facilities and mentorship.

Award 1st Place + $50K

Tulane Demo Day Victory

Won first place and $50,000 at Tulane Innovation Institute's Demo Day, recognizing Informuta's innovative approach and market potential.

Competition 4th Place Overall

Rice Business Plan Competition

Placed fourth overall in the prestigious Rice Business Plan Competition, one of the world's richest and largest graduate-level student startup competitions.

Leadership Industry Recognition

CEO Recognition

Kalen Hall, PhD, highlighted as a distinguished Tulane University graduate and emerging leader in biotech innovation.

Media Public Outreach

BIO from the Bayou Podcast

Featured on the BIO from the Bayou podcast, discussing Informuta's journey through business competitions and commercialization strategy.

Mentorship Strategic Support

Green Wave Innovation Network

Selected for the Tulane Innovation Institute Green Wave Innovation Network mentoring program, connecting with industry experts and advisors.

Competition Winner & Judge

Open MIC Night Success

Won the inaugural Tulane Innovation Institute Open MIC Night competition. CEO Kalen Hall later served as a judge for subsequent competitions.

Recognition Media Coverage

Startup Spotlights

Featured in multiple startup spotlights and innovation showcases, highlighting Informuta's potential to transform infectious disease diagnostics.

Stay Connected

Follow Our Progress

From scientific validation to clinical deployment, join us on the path to making resistance forecasting a reality.